Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Advances in Diagnosis and Management of Cutaneous Adverse Drug Reactions : Current and Future Trends / / edited by Neil H. Shear, Roni P. Dodiuk-Gad
| Advances in Diagnosis and Management of Cutaneous Adverse Drug Reactions : Current and Future Trends / / edited by Neil H. Shear, Roni P. Dodiuk-Gad |
| Edizione | [1st ed. 2019.] |
| Pubbl/distr/stampa | Singapore : , : Springer Singapore : , : Imprint : Adis, , 2019 |
| Descrizione fisica | 1 online resource (XII, 314 p. 95 illus., 91 illus. in color.) |
| Disciplina | 353.998 |
| Soggetto topico |
Pharmacy
Pharmacology Drug Safety and Pharmacovigilance Pharmacology/Toxicology |
| ISBN | 981-13-1489-6 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Section I. Introduction -- 1. Introduction: Classification, Terminology, Epidemiology and Etiology of Cutaneous Adverse Drug Reactions -- Section II. Pathomechanisms of Cutaneous Adverse Drug Reactions -- 2. Immunology of Cutaneous Adverse Drug Reactions -- 3. Pharmacogenomics and Cutaneous Adverse Drug Reactions -- 4 Viral Reactivation in Cutaneous Adverse Drug Reactions -- 5. Using Technology to Learn About Immunology of Cutaneous Adverse Drug Reactions -- Section III. Clinical Perspectives of Cutaneous Adverse Drug Reactions -- 6. Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis (Epithelial Necrolysis) -- 7. Drug Reaction with Eosinophilia and Systemic Symptoms -- 8. Acute Generalized Exanthematous Pustulosis -- 9. Urticarial Reactions to Drugs -- 10. Dermatological Adverse Events from Cancer Treatments -- 11. Cutaneous Adverse Drug Reactions in Pediatric Population -- 12. Cutaneous Drug Reactions in the Elderly -- 13. Cutaneous Adverse Drug Reactions in Human Immunodeficiency Virus Patients -- 14. Cutaneous Adverse Drug Reactions from Anti-Tuberculosis Treatment -- Section IV. Approach to the Patient with a Cutaneous Adverse Drug Reaction -- 15. Practical Approach to Diagnosis and Management of Cutaneous Adverse Drug Reactions -- 16. Histopathology of Severe Drug Eruptions -- 17. Evaluation of Drug Safety Literature: A Guide for the Practicing Dermatologist -- 18. In vitro and in vivo tests in Cutaneous Adverse Drug Reactions -- 19. Pharmacovigilance of Cutaneous Adverse Drug Reactions -- Section V. Epilogue -- 20. Future Directions and Unmet Research Needs in Cutaneous Adverse Drug Reactions -- 21. Atlas of Cutaneous Adverse Drug Reactions. |
| Record Nr. | UNINA-9910350239403321 |
| Singapore : , : Springer Singapore : , : Imprint : Adis, , 2019 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Advances in Genomics : Methods and Applications / / edited by Vijai Singh
| Advances in Genomics : Methods and Applications / / edited by Vijai Singh |
| Autore | Singh Vijai |
| Edizione | [1st ed. 2024.] |
| Pubbl/distr/stampa | Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2024 |
| Descrizione fisica | 1 online resource (424 pages) |
| Disciplina | 576.5 |
| Soggetto topico |
Genetics
Genomics Genetic transcription Pharmacovigilance Synthetic Biology Biology - Technique Genetics and Genomics Gene Transcription Drug Safety and Pharmacovigilance Biological Techniques |
| ISBN |
9789819731695
9789819731688 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Chapter 1. Introduction to genomics and their applications -- Chapter 2. Methods for generating genomics data -- Chapter 3. Computational tools for genomics data analysis -- Chapter 4. Gene and genome annotation -- Chapter 5. Transcriptomics and their significance -- Chapter 6. DNA barcoding and its applications -- Chapter 7. Next-generation genome sequencing and its use -- Chapter 8. Genome-wise analysis for drug targeting -- Chapter 9. Functional genomics -- Chapter 10. Metagenomics -- Chapter 11. Synthetic genomics.-Chapter 12. Microarray in genomics -- Chapter 13. Nutrigenomics -- Chapter 14. Role of synthetic biology in genomics -- Chapter 15. Role of genome editing in genomics -- Chapter 16. Mitochondrial genomics and their clinical use -- Chapter 17. Chloroplast genomics and their uses in crop improvement -- Chapter 18. Microfluidics in genomics -- Chapter 19. Cell-free systems for genomics -- Chapter 20. Artificial intelligence in genomics. |
| Record Nr. | UNINA-9910878988203321 |
Singh Vijai
|
||
| Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2024 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Angiotensin-converting Enzyme Inhibitors vs. Angiotensin Receptor Blockers : A Critical Analysis of Antihypertensive Strategies: A Machine-Generated Literature Overview / / edited by Mukesh Nandave
| Angiotensin-converting Enzyme Inhibitors vs. Angiotensin Receptor Blockers : A Critical Analysis of Antihypertensive Strategies: A Machine-Generated Literature Overview / / edited by Mukesh Nandave |
| Autore | Nandave Mukesh |
| Edizione | [1st ed. 2024.] |
| Pubbl/distr/stampa | Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2024 |
| Descrizione fisica | 1 online resource (609 pages) |
| Disciplina | 615 |
| Soggetto topico |
Pharmacology
Pharmacovigilance Medicine - Research Biology - Research Clinical biochemistry Therapeutics Drug Safety and Pharmacovigilance Biomedical Research Medical Biochemistry |
| ISBN | 981-9773-80-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Chapter 1_ Introduction of the renin-angiotensin-aldosterone system (RAAS) -- Chapter 2_ Role of anti-hypertensive agents in cardiovascular disorders -- Chapter 3_ (ACE) Angiotensin-converting enzyme inhibitors: Preferred RAAS inhibitor in high-risk patients as compared to angiotensin receptor blockers (ARBs) -- Chapter 4_ Role of (ACE) angiotensin-converting enzyme inhibitors in transforming renin–angiotensin system -- Chapter 5_ The effect of (ACE) Angiotensin-converting enzyme inhibitors vs angiotensin receptor blockers on insulin resistance in hypertensive patients -- Chapter 6_ Role of (ACE) Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in acute heart failure -- Chapter 7_ Immunomodulator activity of (ACE) Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in hypertensive patients -- Chapter 8_ Role of (ACE) Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in peripheral artery disease -- Chapter 9_ Role of (ACE) Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in covid-19 patients -- Chapter 10_ Recent trends in the management of hypertension through RAAS inhibition. |
| Record Nr. | UNINA-9910899893503321 |
|
Nandave Mukesh
|
||
| Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2024 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Antibiotic Resistance in the Environment : A Worldwide Overview / / edited by Célia M. Manaia, Erica Donner, Ivone Vaz-Moreira, Peiying Hong
| Antibiotic Resistance in the Environment : A Worldwide Overview / / edited by Célia M. Manaia, Erica Donner, Ivone Vaz-Moreira, Peiying Hong |
| Edizione | [1st ed. 2020.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2020 |
| Descrizione fisica | 1 online resource (XII, 344 p. 1 illus.) |
| Disciplina | 616.9041 |
| Collana | The Handbook of Environmental Chemistry |
| Soggetto topico |
Environmental chemistry
Pharmacology Microbiology Pharmacovigilance Medical microbiology Environmental Chemistry Drug Safety and Pharmacovigilance Medical Microbiology Resistència als medicaments Efecte dels medicaments sobre els microorganismes Química ambiental |
| Soggetto genere / forma | Llibres electrònics |
| ISBN | 3-030-55065-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Antibiotic resistance in the environment: expert perspectives -- Antibiotic resistant bacteria in wildlife -- Genomic surveillance for One Health antimicrobial resistance: understanding human, animal, and environmental reservoirs and transmission -- Antibiotic resistance in pharmaceutical industry effluents and effluent-impacted environments -- Antibiotic resistance in municipal wastewater: A special focus on hospital effluents -- Control strategies to combat dissemination of antibiotic resistance in urban water systems -- Antibiotic resistance, sanitation and public health -- Antibiotic resistance and sanitation in India: current situation and future perspectives -- Mitigating antimicrobial resistance risks when using reclaimed municipal wastewater for agriculture -- Antibiotic resistance in soil -- Religious Mass Gathering (Hajj) and Antimicrobial Resistance: From Challenges to Opportunities -- Human movement and transmission of anti-microbial resistant bacteria. |
| Record Nr. | UNINA-9910416142403321 |
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2020 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Applied Clinical Pharmacokinetics and Pharmacodynamics of Psychopharmacological Agents / / edited by Michael W. Jann, Scott R. Penzak, Lawrence J. Cohen
| Applied Clinical Pharmacokinetics and Pharmacodynamics of Psychopharmacological Agents / / edited by Michael W. Jann, Scott R. Penzak, Lawrence J. Cohen |
| Edizione | [1st ed. 2016.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Adis, , 2016 |
| Descrizione fisica | 1 online resource (597 p.) |
| Disciplina | 610 |
| Soggetto topico |
Psychopharmacology
Pharmacy Drug Safety and Pharmacovigilance |
| ISBN | 3-319-27883-5 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Section 1. General Pharmacokinetic and Pharmacodynamic Principles of Psychopharmacological Agents -- 1. Pharmacokinetic Properties -- 2. Pharmacodynamic Properties -- 3. PET Scan and Other Biomarkers -- 4. Population Pharmacokinetics -- 5. Drug Transporters (esp. Blood Brain Barrier) -- 6. Pharmacogenomics -- Section 2. Clinical Pharmacokinetics and Pharmacodynamics of Psychopharmacological Drug Classes -- 7. Antipsychotics – oral typical agents, oral atypical agents, and long-acting injectable (LAI) antipsychotics -- 8. Mood Stabilizers -- 9. Antidepressants – tricyclics, selective serotonergic reuptake inhibitors, serotonergic noradrenergic reuptake inhibitors, monoamine oxidase inhibitors, and other antidepressants -- 10. Benzodiazepines and Other Sedative Hypnotics/Anxiolytics -- 11. Opioid Analgesics -- 12. Stimulants and Other Non-Stimulants for ADHD -- 13. Cholinesterase Inhibitors and Other Antidementa Agents -- 14. Anti-Addiction Agents -- 15. Anesthetics -- Section 3. Clinically Significant Drug Interactions With Psychopharmacological Agents -- 16. Antipsychotics -- 17. Mood Stabilizers -- 18. Antidepressants -- 19. Benzodiazepines and Other Sedative Hypnotics/Anxiolytics -- 20. Opioid Analgesics -- 21. Stimulants and Other Non-Stimulants for ADHD -- 22. Cholinesterase Inhibitors and Other Antidementa Agents -- 23. Anti-Addiction Agents -- 24. Anesthetics. |
| Record Nr. | UNINA-9910254508503321 |
| Cham : , : Springer International Publishing : , : Imprint : Adis, , 2016 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Atlas of Osteoarthritis / / by Nigel Arden, Francisco Blanco, C. Cooper, Ali Guermazi, Daichi Hayashi, David Hunter, M. Kassim Javaid, Francois Rannou, Frank Roemer, Jean-Yves Reginster
| Atlas of Osteoarthritis / / by Nigel Arden, Francisco Blanco, C. Cooper, Ali Guermazi, Daichi Hayashi, David Hunter, M. Kassim Javaid, Francois Rannou, Frank Roemer, Jean-Yves Reginster |
| Autore | Arden Nigel |
| Edizione | [1st ed. 2014.] |
| Pubbl/distr/stampa | Tarporley : , : Springer Healthcare Ltd. : , : Imprint : Springer Healthcare, , 2014 |
| Descrizione fisica | 1 online resource (99 p.) |
| Disciplina |
353998
610 616723 |
| Soggetto topico |
Rheumatology
Pharmacy Family medicine Drug Safety and Pharmacovigilance General Practice / Family Medicine |
| ISBN | 1-910315-16-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Introduction: historical and current perspectives on osteoarthritis -- Epidemiology of osteoarthritis -- Pathophysiology of osteoarthritis -- Clinical features and diagnosis of osteoarthritis -- Assessing joint damage in osteoarthritis -- Treatment of osteoarthritis. |
| Record Nr. | UNINA-9910300061003321 |
|
Arden Nigel
|
||
| Tarporley : , : Springer Healthcare Ltd. : , : Imprint : Springer Healthcare, , 2014 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Benefit-Risk Assessment of Medicines : The Development and Application of a Universal Framework for Decision-Making and Effective Communication / / by James Leong, Sam Salek, Stuart Walker
| Benefit-Risk Assessment of Medicines : The Development and Application of a Universal Framework for Decision-Making and Effective Communication / / by James Leong, Sam Salek, Stuart Walker |
| Autore | Leong James |
| Edizione | [1st ed. 2015.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Adis, , 2015 |
| Descrizione fisica | 1 online resource (326 p.) |
| Disciplina |
306
353998 610 |
| Soggetto topico |
Pharmacy
Medical research Drug Safety and Pharmacovigilance Quality of Life Research |
| ISBN | 3-319-15805-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Prologue -- Preface -- Overview -- Approaches to utilising decision-making framework -- Benefit-risk assessment of medicines by pharmaceutical companies and regulatory authorities -- Development of a universal benefit-risk framework and template -- Implementation of the benefit-risk assessment template by mature agencies -- Implementation of the benefit- risk summary template by a maturing agency: A case study -- Communicating benefit-risk decisions by US FDA, EMA, TGA and Health Canada -- Conclusions and future directions -- References. |
| Record Nr. | UNINA-9910300234003321 |
|
Leong James
|
||
| Cham : , : Springer International Publishing : , : Imprint : Adis, , 2015 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Cancer Policy: Pharmaceutical Safety / / edited by June M. McKoy, Dennis P. West
| Cancer Policy: Pharmaceutical Safety / / edited by June M. McKoy, Dennis P. West |
| Edizione | [1st ed. 2019.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2019 |
| Descrizione fisica | 1 online resource (129 pages) |
| Disciplina | 615.10289 |
| Collana | Cancer Treatment and Research |
| Soggetto topico |
Oncology
Pharmacy Oncology Drug Safety and Pharmacovigilance |
| ISBN | 3-319-43896-4 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Pharmacovigilance programs: Do they improve Cancer Drug Safety? -- Impact of Cost on the Safety of Cancer pharmaceuticals -- Assessing pharmaceutical safety in Geriatric Oncology -- Cancer co-Morbidity: Implications for Drug Safety -- Statistical aids to signal generation: Are they effective in Identifying Adverse Cancer Drug Reactions? -- Pharmacovigilance of alternative medications in the Cancer Setting -- Key elements in Adverse Drug Interaction Safety Signals: evaluation of individual case reports in oncology -- Biosimilars: Are they really safe? -- Natural Language processing: improving the identification and communication of Cancer Drug Safety -- The Drug Shortage Crisis in the United States: Impact on cancer pharmaceutical safety -- Anatomy of Risk Evaluation and Mitigation Strategies (REMS) -- Cancer Drug Toxicity: Moving from patient to Survivor. |
| Record Nr. | UNINA-9910337507003321 |
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2019 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Carbon Nanotubes for Targeted Drug Delivery / / by Md Saquib Hasnain, Amit Kumar Nayak
| Carbon Nanotubes for Targeted Drug Delivery / / by Md Saquib Hasnain, Amit Kumar Nayak |
| Autore | Hasnain Md Saquib |
| Edizione | [1st ed. 2019.] |
| Pubbl/distr/stampa | Singapore : , : Springer Singapore : , : Imprint : Springer, , 2019 |
| Descrizione fisica | 1 online resource (XIV, 106 p. 21 illus., 16 illus. in color.) |
| Disciplina | 620.115 |
| Collana | SpringerBriefs in Applied Sciences and Technology |
| Soggetto topico |
Nanotechnology
Pharmaceutical technology Pharmacy Pharmaceutical Sciences/Technology Nanotechnology and Microengineering Drug Safety and Pharmacovigilance |
| ISBN | 981-15-0910-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Introduction -- Chemical and physical properties of Carbon Nanotubes -- Classification of Carbon Nanotubes -- Preparation of Carbon Nanotubes -- Functionalization of Carbon Nanotubes -- Carbon Nanotubes Characterization -- Applications of Carbon Nanotubes -- Carbon Nanotubes absorption and transportation -- Carbon Nanotubes Toxicity Consideration -- Carbon Nanotubes Regulatory considerations -- Carbon Nanotubes Clinical trials and market status -- Conclusion. |
| Record Nr. | UNINA-9910357827303321 |
|
Hasnain Md Saquib
|
||
| Singapore : , : Springer Singapore : , : Imprint : Springer, , 2019 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Cardiovascular Safety in Drug Development and Therapeutic Use : New Methodologies and Evolving Regulatory Landscapes / / by J. Rick Turner, Dilip R. Karnad, Snehal Kothari
| Cardiovascular Safety in Drug Development and Therapeutic Use : New Methodologies and Evolving Regulatory Landscapes / / by J. Rick Turner, Dilip R. Karnad, Snehal Kothari |
| Autore | Turner J. Rick |
| Edizione | [1st ed. 2017.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Adis, , 2017 |
| Descrizione fisica | 1 online resource (XXVI, 333 p. 2 illus. in color.) |
| Disciplina | 353.998 |
| Soggetto topico |
Pharmacy
Cardiology Drug Safety and Pharmacovigilance |
| ISBN | 3-319-40347-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | The Central Importance of Cardiovascular Safety in Contemporary New Drug Development -- The Biological Basis of Drug Responses -- Cardiovascular Structure, Function, Pathophysiology, & Disease -- The Current Regulatory Landscape -- The "Comprehensive In Vitro Proarrhythmia Assay" Initiative -- The "Early ECG Assessment" Initiative -- The "Submission of Extended Digital ECG Data" Initiative -- Meta-analysis and Meta-methodology -- Current Regulatory Landscapes and their Potential Evolution -- Off-target Blood Pressure Responses to Non-cardiovascular Drugs -- Oncology Drug Development and Therapeutics: Cardiotoxicity Considerations -- Postmarketing Surveillance -- Regulatory Perspectives on General Drug Safety -- Future Directions in Cardiovascular Safety -- References. |
| Record Nr. | UNINA-9910254496803321 |
|
Turner J. Rick
|
||
| Cham : , : Springer International Publishing : , : Imprint : Adis, , 2017 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
